BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 3.44 EUR -0.86% Market Closed
Market Cap: 75.2m EUR
Have any thoughts about
BRAIN Biotech AG?
Write Note

BRAIN Biotech AG
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BRAIN Biotech AG
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
BRAIN Biotech AG
XETRA:BNN
Cash from Investing Activities
-€1.9m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Wacker Chemie AG
XETRA:WCH
Cash from Investing Activities
-€505.6m
CAGR 3-Years
-2%
CAGR 5-Years
-10%
CAGR 10-Years
0%
Evonik Industries AG
XETRA:EVK
Cash from Investing Activities
-€785m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
-11%
Covestro AG
XETRA:1COV
Cash from Investing Activities
-€749m
CAGR 3-Years
31%
CAGR 5-Years
2%
CAGR 10-Years
N/A
AlzChem Group AG
XETRA:ACT
Cash from Investing Activities
-€20.5m
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Symrise AG
XETRA:SY1
Cash from Investing Activities
-€392.9m
CAGR 3-Years
-17%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
No Stocks Found

BRAIN Biotech AG
Glance View

Market Cap
75.2m EUR
Industry
Chemicals

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN Intrinsic Value
5.17 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is BRAIN Biotech AG's Cash from Investing Activities?
Cash from Investing Activities
-1.9m EUR

Based on the financial report for Jun 30, 2024, BRAIN Biotech AG's Cash from Investing Activities amounts to -1.9m EUR.

What is BRAIN Biotech AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
2%

Over the last year, the Cash from Investing Activities growth was 37%. The average annual Cash from Investing Activities growth rates for BRAIN Biotech AG have been 2% over the past three years .

Back to Top